Jay Bradner appointed as Amgen's R&D leader, David Reese becomes chief technology officer
Amgen has appointed former Novartis research executive Jay Bradner to a top role in its research leadership, while shifting current R&D chief David Reese to lead technology and AI. Bradner previously served as head of Novartis' research arm, the Novartis Institutes for Biomedical Research, before being succeeded by Fiona Marshall. After leaving Novartis, Bradner worked as a clinician at the Dana-Farber Cancer Institute and Brigham & Women's Hospital.